Delisting riskPopularity #5,126
Soligenix (SNGX)
Develops rare-disease therapeutics and heat-stable biodefense vaccine candidates.
$0.3851
After hours+0.00 (+0.50%)
At close$0.3832(−0.47%)
Something off on this page? Send us feedback.
Next report
Nov 6, 26
estimated · in 44 days
EPS estimate
−$0.12
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported−$1.14−$1.06−$0.82−$0.58$0.32−$0.28−$0.12Pending
Estimate−$0.95−$0.67−$0.79−$0.63−$0.27−$0.30−$0.16−$0.12
Surprise−20.0%−58.2%−3.8%+7.9%+218.5%+6.7%+22.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported$6.4K—————$0Pending
Estimate$200.0K———————
Surprise−96.8%———————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.06 | — | — |
| Sep 2027 | −$0.06 | — | — |
| Jun 2027 | −$0.06 | — | — |
| Mar 2027 | −$0.07 | — | — |
| Dec 2026 | −$0.09 | — | — |
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.16 | −$0.12 | +22.6% |
| May 2026 | −$0.30 | −$0.28 | +6.7% |
| Apr 2026 | −$0.27 | $0.32 | +218.5% |
| Nov 2025 | −$0.63 | −$0.58 | +7.9% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.06 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.06 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.06 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.07 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.09 | — | — | $0 | — | — | — |
| Nov 6, 2026 | −$0.12 | — | — | $0 | — | — | — |
| Aug 7, 2026 | −$0.16 | −$0.12 | +22.6% | — | $0 | — | +3.5% |
| May 8, 2026 | −$0.30 | −$0.28 | +6.7% | — | — | — | −4.9% |
| Apr 3, 2026 | −$0.27 | $0.32 | +218.5% | — | — | — | 0.0% |
| Nov 7, 2025 | −$0.63 | −$0.58 | +7.9% | — | — | — | +7.0% |
| Aug 14, 2025 | |||||||
| May 9, 2025 | |||||||
| Mar 21, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 10, 2024 | |||||||
| Mar 15, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 21, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 14, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 26, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 15, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 11, 2017 | |||||||
| Mar 27, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 24, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 12, 2015 |